DEVELOPMENT AND PRECLINICAL EVALUATION OF VT-1598, A BROAD-SPECTRUM AND SAFE ANTIFUNGAL TO PREVENT FUNGAL (MOLD) INFECTIONS OF BATTLEFIELD WOUNDS
$2,772,142FY2015Department of the ArmyDOD
Innocrin Pharmaceuticals, Inc.
Investigators
View source on USAspending →DEVELOPMENT AND PRECLINICAL EVALUATION OF VT-1598, A BROAD-SPECTRUM AND SAFE ANTIFUNGAL TO PREVENT FUNGAL (MOLD) INFECTIONS OF BATTLEFIELD WOUNDS · GrantIndex